Results 161 to 170 of about 1,018,827 (204)
Neuro-oncological ventral antigen 1 regulates liver cancer stem cell properties and Lenvatinib resistance via targeting SOX4. [PDF]
Lan H +6 more
europepmc +1 more source
Retraction notice to "BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits" [Redox Biology 20 (2019) 427-441]. [PDF]
Zhao X +19 more
europepmc +1 more source
Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma. [PDF]
Lopez A +13 more
europepmc +1 more source
Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer. [PDF]
Liu X +8 more
europepmc +1 more source
[Expression of Concern] Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell‑like side population cells. [PDF]
Zhu D +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2016
The cancer stem cell model in solid tumors has evolved significantly from the early paradigm shifting work highlighting parallels between the stem cell hierarchy in hematologic malignancies and solid tumors. Putative stem cells can dedifferentiated, be induced by context, and be the result of accumulated genetic mutations.
Wendy A, Woodward, Richard P, Hill
openaire +2 more sources
The cancer stem cell model in solid tumors has evolved significantly from the early paradigm shifting work highlighting parallels between the stem cell hierarchy in hematologic malignancies and solid tumors. Putative stem cells can dedifferentiated, be induced by context, and be the result of accumulated genetic mutations.
Wendy A, Woodward, Richard P, Hill
openaire +2 more sources
Journal of Clinical Oncology, 2008
Cellular heterogeneity in cancer was observed decades ago by studies in mice which showed that distinct subpopulations of cells within a tumor mass are capable of driving tumorigenesis. Conceptualized from this finding was the stem-cell hypothesis for cancer, which suggests that only a specific subset of cancer cells within each tumor is responsible ...
Cheong J, Lee +2 more
openaire +2 more sources
Cellular heterogeneity in cancer was observed decades ago by studies in mice which showed that distinct subpopulations of cells within a tumor mass are capable of driving tumorigenesis. Conceptualized from this finding was the stem-cell hypothesis for cancer, which suggests that only a specific subset of cancer cells within each tumor is responsible ...
Cheong J, Lee +2 more
openaire +2 more sources
Current Protocols in Stem Cell Biology, 2008
AbstractThis unit describes protocols for working with colon cancer stem cells. To work with these cells one must start by generating single‐cell suspensions from human colon cancer tissue. These cell suspensions are sorted using flow cytometry–assisted cell sorting to fractionate the cells into tumor‐initiating and nontumor‐initiating subsets.
Antonija, Kreso +1 more
openaire +2 more sources
AbstractThis unit describes protocols for working with colon cancer stem cells. To work with these cells one must start by generating single‐cell suspensions from human colon cancer tissue. These cell suspensions are sorted using flow cytometry–assisted cell sorting to fractionate the cells into tumor‐initiating and nontumor‐initiating subsets.
Antonija, Kreso +1 more
openaire +2 more sources
Gut, 2007
Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106–130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options ...
L, Ricci-Vitiani +4 more
openaire +2 more sources
Colorectal cancer (CRC) is the third most common form of cancer and the second cause of cancer-related death in the Western world, leading to 655,000 deaths worldwide per year (Jemal et al. in CA Cancer J Clin 56:106–130, 2006). Despite the emergence of new targeted agents and the use of various therapeutic combinations, none of the treatment options ...
L, Ricci-Vitiani +4 more
openaire +2 more sources

